Quantitative phenotyping of chromatic dysfunction in best macular dystrophy

Archives of Ophthalmology

Volumn 123, Issue 7, 2005, Pages 944-949

  Campos, Sónia H ^a   Forjaz, Vasco ^a,b   Kozak, Lajos R ^a,b,c   Silva, Eduardo ^a   Castelo Branco, Miguel ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Institute of Biomedical Research in Light and Image   (Portugal)

^c INSTITUTE FOR PSYCHOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COLOR; COLOR DISCRIMINATION; COLOR VISION; COLOR VISION DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; OUTCOMES RESEARCH; PERFORMANCE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOPHYSICS; QUANTITATIVE ANALYSIS; RETINA MACULA VITELLIFORM DEGENERATION; STATISTICAL SIGNIFICANCE; VISUAL ACUITY; COLOR VISION TEST; CONTRAST SENSITIVITY; METHODOLOGY; PATHOPHYSIOLOGY; PSYCHOPHYSIOLOGY; RETINA CONE; RETINA MACULA DEGENERATION;

ADULT; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; CONES (RETINA); CONTRAST SENSITIVITY; HUMANS; MACULAR DEGENERATION; PHENOTYPE; PSYCHOPHYSIOLOGY; VISUAL ACUITY;

EID: 22844439182     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.7.944     Document Type: Article

References (41)

1. Regan BC, Reffin JP, Mollon JD. Luminance noise and the rapid determination of discrimination ellipses in colour deficiency. Vision Res. 1994;34:1279-1299.
2. Roth A, Lanthony P. Vision des couleurs. In: Risse JF, ed. Exploration de la Fonction Visuelle. Paris, France: Masson; 1999:129-151.
3. Pokorny J, Smith VC, Ernest JT. Macular color vision defects. Int Ophthalmol Clin. 1980;20:53-81.
4. Pokorny J, Smith VC, Verriest G, Pinckers A. Congenital and Acquired Color Vision Deficits. New York, NY: Grune & Stratton: 1979.
5. Brecher R, Bird AC. Adult vitelliform macular dystrophy. Eye. 1990;4:210-215.
6. Best F. Über eine hereditäre Maculaaffektion: Beiträge zur Vererbungslehre. Z Augenheilkd. 1905;13:199-212.
7. Deutman AF. Electro-oculography in families with vitelliform dystrophy of the fovea: detection of the carrier state. Arch Ophthalmol. 1969;81:305-316.
8. Krill AE, Morse PA, Potts AM, Klien BA. Hereditary vitelliruptive macular degeneration. Am J Ophthalmol. 1966;61:1405-1415.
9. Bard LA, Cross HE. Genetic counseling of families with Best macular dystrophy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1975;79:OP865-OP873.
10. Gass JD. A clinicopathologic study of a peculiar foveomacular dystrophy. Trans Am Ophthalmol Soc. 1974;72:139-156.
11. Mohler CW, Fine SL. Long-term evaluation with Best's vitelliform dystrophy. Ophthalmology. 1981;88:688-692.
12. Godel V, Chaine G, Regenbogen L, Coscas G. Best's vitelliform macular dystrophy. Acta Ophthalmol Suppl. 1986;175:1-31.
13. Clemett R. Vitelliform dystrophy: long-term observations on New Zealand pedigrees. Aust N Z J Ophthalmol. 1991;19:221-227.
14. Weingeist TA, Kobrin JL, Watzke RC. Histopathology of Best's macular dystrophy. Arch Ophthalmol. 1982;100:1108-1114.
15. O'Gorman S, Flaherty WA, Fishman GA, Berson EL. Histopathologic findings in Best's vitelliform macular dystrophy. Arch Ophthalmol. 1988;106:1261-1268.
16. Frangieh GT, Green WR, Fine SL. A histopathologic study of Best's macular dystrophy. Arch Ophthalmol. 1982;100:1115-1121.
17. Patrinely J. Lewis RA, Font R. Foveomacular vitelliform dystrophy, adult type . Ophthalmology. 1985;92:1712-1718.
18. Miller SA. Multifocal Best's vitelliform dystrophy. Arch Ophthalmol. 1977;95:984-990.
19. Marquardt A, Stohr H, Passmore LA, Kramer F, Rivera A, Weber BH. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset macular dystrophy (Best's disease). Hum Mol Genet. 1998;7:1517-1525.
20. Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998:19:241-247.
21. Lotery AJ, Munier FL, Fishman GA, et al. Allelic variation in the VMD2 gene in Best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:1291-1296.
22. Eksandh L, Bakall B, Bauer B, Wadelius C, Andreasson S. Best's vitelliform macular dystrophy caused by a new mutation (Val89Ala) in the VMD2 gene. Ophthalmic Genet. 2001;22:107-115.
23. Palomba G, Rozzo C, Angius A, Pierrottet CO, Orzalesi N, Pirastu M. A novel spontaneous missense mutation in VMD2 gene is a cause of a Best macular dystrophy sporadic case. Am J Ophthalmol. 2000;129:260-262.
24. Bakall B, Marknell T, Ingvast S, et al. The mutation spectrum of the bestrophin protein: functional implications. Hum Genet. 1999;104:383-389.
25. Kramer F, White K, Pauleikhoff D, et al. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet. 2000;8:286-292.
26. Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A. 2002;99:4008-4013.
27. Marmorstein LY, McLaughlin PJ, Stanton JB, Van L, Crabb JW, Marmorstein AD. Bestrophin interacts physically and functionally with protein phosphatase 2A. J Biol Chem. 2002;277:30591-30597.
28. Francois J, De Rouck A, Fernandez-Sasso D. Electro-oculography in vitelliform degeneration of the macula. Arch Ophthalmol. 1967;77:726-733.
29. Palmowski AM, Allgayer R, Heinemann-Vernaleken B, Scherer V, Ruprecht KW. Detection of retinal dysfunction in vitelliform macular dystrophy and the multifocal ERG (MF-ERG). Doc Ophthalmol. 2003;106:145-152.
30. Scholl HP, Kremers J, Apfelstedt-Sylla E, Zrenner E. L- and M-cone driven ERGs are differently altered in Best's macular dystrophy. Vision Res. 2000;40:3159-3168.
31. Falsini B, Porciatti V, Porrello G, et al. Macular flicker electroretinograms in Best vitelliform dystrophy. Curr Eye Res. 1996;15:638-646.
32. Wajima R, Chater SB, Katsumi O, Mehta MC, Hirose T. Correlating visual acuity and electrooculogram recordings in Best's disease. Ophthalmologica. 1993;207:174-181.
33. Massof RW, Fleischman JA, Fine SL, Yoder F. Flicker fusion thresholds in Best macular dystrophy. Arch Ophthalmol. 1977;95:991-994.
34. DeLint PJ, Berendschot TT, van Norren D. A comparison of the optical Stiles-Crawford effect and retinal densitometry in a clinical setting. Invest Ophthalmol Vis Sci. 1998;39:1519-1523.
35. Burns SA, Elsner AE. Localizing color vision deficiencies in eye disease. In: Drum B, Verriest G, eds. Colour Vision Deficiencies. The Hague, the Netherlands: Dr W Junk Publishers; 1988:167-180. Docum Ophthal Proc Series.
36. Scullica L, Falsini B. Diagnosis and classification of macular degenerations: an approach based on retinal function testing. Doc Ophthalmol. 2001;102:237-250.
37. Fishman G, Baca W, Alexander KR, Derlacki DK, Glenn AM, Viana M. Visual acuity in patients with Best vitelliform macular dystrophy. Ophthalmology. 1993;100:1665-1670.
38. Castelo-Branco M, Faria P, Forjaz V, Kozak LR, Azevedo H. Simultaneous comparison of relative damage to chromatic pathways in ocular hypertension and glaucoma. Invest Ophthalmol Vis Sci. 2004;45:499-505.
39. Marmorstein AD, Marmorstein LY, Rayborn M, Wang X, Hollyfield JG, Petrukhin K. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci U S A. 2000;97:12758-12763.
40. Cideciyan AV, Jacobson SG. An alternative phototransduction model for human rod and cone ERG a-waves: normal parameters and variation with age. Vision Res. 1996;36:2609-2621.
41. Hood DC, Birch DG, Pepperberg DR. The trailing edge of the photoreceptor response from human cones derived using a two-flash ERG paradigm. In: Visual Science and Its Applications. Washington, DC: Optical Society of America; 1996:64-67.